Understanding in depth how tumors evolve to become malignant is the objective of a study recently published in the journal ...

Recently, Prof. Huang Qing's group from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences studied ...

Good Morning America’ meteorologist Sam Champion returned to work Friday, October 18, following a skin cancer scare that ...

Killing breast cancer cells in a way that trains the immune system to recognize and destroy residual cancer cells could offer ...

On the Friday, October 18, episode of Good Morning America, the beloved weatherman gave viewers an inside look into his skin ...

ABC meteorologist Sam Champion appeared on “Good Morning America” with a scar under his eye where cancer was recently removed ...

The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...

Yousef Zakharia, MD, discussed some of the available combination therapies for non–clear Cell renal cell carcinoma treatment.

The innate immune response is the body's first line of defense against infection, and a successful immune defense takes a ...

Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the ...

Dual Immunotherapy Plus Chemotherapy Benefits Specific Subset of Patients With Lung Cancer Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell ...

Understanding in depth how tumors evolve to become malignant is the objective of the latest study led by the Cell Plasticity ...